Fig. 3From: Are breast cancer patients with suboptimal adherence to cardiovascular treatment more likely to discontinue adjuvant endocrine therapy? Competing risk survival analysis in a nationwide cohort of postmenopausal womenCumulative incidence of AET discontinuation according to different levels of cardiovascular treatment adherenceBack to article page